台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效

智擎

(4162)
可現股當沖
  • 股價
    89.9
  • 漲跌
    ▼1.3
  • 漲幅
    -1.43%
  • 成交量
    417
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智擎 (4162)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/05/27     後一日»

券商獲利排行 - 2025/05/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.04%35.9035.9-3803890.8090.889.9
  1.00%21.94.617.3-12122491.29191.389.9
  1.75%20.8020.8-1301391.5091.589.9
  1.72%20.5020.5-1301391.5091.589.9
  1.72%20.4020.4-1301391.5091.589.9
  0.41%16.1-3.119.2-15284391.291.391.289.9
  1.53%14014-1001091.3091.389.9
  2.02%11.1011.1-60691.8091.889.9
  1.72%11011-70791.5091.589.9
  0.99%10.8010.8-1201290.8090.889.9
  1.56%10010-60791.39291.389.9
  2.07%9.509.5-50591.8091.889.9
  1.71%9.40.78.8-51691.69191.789.9
  1.55%8.508.5-60691.3091.389.9
  1.21%6.606.6-6069109189.9
  0.38%5.9-3.19-7101791.391.591.289.9
  1.86%5.105.1-30391.6091.689.9
  1.10%505-50590.9090.989.9
  1.78%4.904.9-30391.5091.589.9
  1.50%4.104.1-30391.3091.389.9
  2.18%404-20291.9091.989.9
  2.12%3.903.9-20291.9091.989.9
  1.43%3.903.9-30391.2091.289.9
  1.85%3.403.4-10291.591.291.689.9
  1.21%3.303.3-3039109189.9
  0.21%3300161691.19191.289.9
  1.10%303-30390.9090.989.9
  0.99%2.702.7-30390.8090.889.9
  0.66%2.40.22.3-12491919189.9
  1.21%2.202.2-2029109189.9
  2.28%2.102.1-1019209289.9
  2.21%202-10191.9091.989.9
  2.07%1.901.9-10191.8091.889.9
  1.96%1.801.8-10191.7091.789.9
  1.86%1.701.7-10191.6091.689.9
  1.86%1.701.7-10191.6091.689.9
  1.86%1.701.7-10191.6091.689.9
  1.86%1.701.7-10191.6091.689.9
  1.86%1.701.7-10191.6091.689.9
  1.77%1.601.6-10191.5091.589.9
  1.75%1.601.6-10191.5091.589.9
  1.75%1.601.600191.591.691.589.9
  1.75%1.601.6-10191.5091.589.9
  1.53%1.401.4-10191.3091.389.9
  1.44%1.301.3-10191.2091.289.9
  1.43%1.301.3-10191.2091.289.9
  1.43%1.301.3-10191.2091.289.9
  1.43%1.301.3-10191.2091.289.9
  1.32%1.201.2-10191.1091.189.9
  1.32%1.201.2-10191.1091.189.9

券商虧損排行 - 2025/05/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.46%-130.60-130.69898091.291.2089.9
  -1.03%-17.8-0.2-17.51419491.191.19189.9
  -1.82%-16.70-16.71010091.691.6089.9
  -1.75%-160-161010091.591.5089.9
  -2.07%-9.50-9.545091.891.890.889.9
  -1.86%-8.50-8.555091.691.6089.9
  -0.74%-7.40.6-8611591.391.291.389.9
  -1.21%-6.60-6.66609191089.9
  -1.43%-6.50-6.555091.291.2089.9
  -1.12%-6.10-6.166090.990.9089.9
  -1.48%-5.40-5.444091.391.3089.9
  -1.10%-50-555090.990.9089.9
  -1.64%-4.50-4.523091.491.491.689.9
  -1.43%-3.90-3.933091.291.2089.9
  -1.39%-3.8-0.6-3.223191.491.590.989.9
  -1.96%-3.60-3.622091.791.7089.9
  -1.59%-2.90-2.922091.491.4089.9
  -1.53%-2.80-2.822091.391.3089.9
  -1.53%-2.80-2.822091.391.3089.9
  -1.48%-2.70-2.722091.391.3089.9
  -0.25%-2.7-1.3-1.41121191.291.391.289.9
  -1.43%-2.60-2.622091.291.2089.9
  -1.43%-2.60-2.622091.291.2089.9
  -0.95%-2.60-2.633090.890.8089.9
  -0.11%-2.4-5.83.4-3202391.291.39189.9
  -1.15%-2.10-2.12209191089.9
  -1.96%-1.80-1.811091.791.7089.9
  -0.99%-1.80-1.822090.890.8089.9
  -0.99%-1.80-1.822090.890.8089.9
  -0.99%-1.80-1.822090.890.8089.9
  -1.86%-1.70-1.711091.691.6089.9
  -1.86%-1.70-1.711091.691.6089.9
  -1.75%-1.60-1.611091.591.5089.9
  -1.75%-1.60-1.611091.591.5089.9
  -0.88%-1.60-1.622090.790.7089.9
  -1.74%-1.60-1.611091.591.5089.9
  -1.64%-1.50-1.511091.491.4089.9
  -1.64%-1.50-1.511091.491.4089.9
  -1.53%-1.40-1.411091.391.3089.9
  -1.53%-1.40-1.411091.391.3089.9
  -1.43%-1.30-1.311091.291.2089.9
  -1.43%-1.30-1.311091.291.2089.9
  -1.43%-1.30-1.311091.291.2089.9
  -1.43%-1.30-1.301091.291.290.989.9
  -1.43%-1.30-1.311091.291.2089.9
  -1.43%-1.30-1.311091.291.2089.9
  -1.43%-1.30-1.311091.291.2089.9
  -0.71%-1.30.1-1.412191.391.391.489.9
  -1.32%-1.20-1.201091.191.190.989.9
  -1.32%-1.20-1.211091.191.1089.9
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章